A newly discovered problem with the Apache helicopter’s transmission is plaguing the Army’s fleet, just as funding woes have pushed the service to drastically cut flight hours and rapidly retire older ...

Minecraft's Java Edition has long been the go-to for PC players, owing to how moddable it is in comparison to its Bedrock counterpart. However, getting a clean multiplayer experience has long ...

I read your response to the woman who wondered why she should invest in Social Security when the stock market would have been far more lucrative (“If I had invested my Social Security in the S&P 500 I ...

Spoiler alert! This story contains details from Season 2 of “Running Point,” currently streaming on Netflix. Kate Hudson makes a reference to her beloved 2003 rom-com, “How to Lose a Guy in 10 Days,” ...

WASHINGTON, D.C. (WKYT) - Kentucky Auditor Allison Ball testified Tuesday during a U.S. House oversight hearing focused on fraud prevention in federally funded programs administered by states, as ...

Running is one of the most approachable forms of exercise. You don’t need a gym membership, a coach, or a lot of gear to begin. If you have comfortable shoes and clothes you can move in, you already ...

The president’s request for 2027 reflects his preoccupation with eliminating programs that support diversity and civil rights. By Luke Broadwater and Michael C. Bender President Trump used his ...

EDMONDS, Wash. — Syreh Sonko is studying nursing at Edmonds College through Washington state's Running Start, but the program that's saving her nearly $30,000 in college costs may soon look different.

President Trump said there would likely be more American casualties as the U.S. military continues strikes against Iran. Photo: The White House Now that is being put to the test, as the U.S. races to ...

Women's Health may earn commission from the links on this page, but we only feature products we believe in. Why Trust Us? While you probably have a favorite way to work out—maybe you’re a runner, HIIT ...

Amgen has terminated its rocatinlimab collaboration with Kyowa Kirin, walking away from the anti-OX40 antibody five years after paying $400 million for rights to the autoimmune disease drug candidate.